Tyrus Capital S.A.M.’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Tyrus Capital S.A.M.’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-133,332	Closed	-$39.7K	–	44
2022 Q4	$39.7K	Buy	+133,332	New	+$26.8K	0.09%	28

Tyrus Capital S.A.M.'s EBACW Position: Q1 2023 in Review

Tyrus Capital S.A.M. sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 133,332 shares — an estimated $39.7K sold.

Tyrus Capital S.A.M. first reported a position in EBACW in Q4 2022 and held it in 1 quarter. The position peaked at $39.7K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Tyrus Capital S.A.M. reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Tyrus Capital S.A.M. sold 133,332 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $39.7K.
Tyrus Capital S.A.M. first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2022 and held it in 1 quarter.
Tyrus Capital S.A.M.'s European Biotech Acquisition Corp. Warrant position peaked at $39.7K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Tyrus Capital S.A.M.'s 13F filing for Q1 2023, filed 15 May 2023.